Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient

Canadian Journal of Cardiology

Volumn 20, Issue SUPPL. A, 2004, Pages

  Fitchett, David ^a   Rockwood, Kenneth ^b   Chan, Benjamin T B ^c   Schultz, Susan ^d   Bogaty, Peter ^e   Gillis, Anne ^f   Arnold, Malcolm ^g   Miller, Fraser ^h   Graham, Michelle M ⁱ   Ghali, William A ^j   Cartier, Raymond ^k   Chow, Chi Ming ^a   Grymonpre, Ruby ^l   Ogilvie, Richard ^d   Rochon, Paula ^d   Niznick, Joel ^m   Grover, Steven ⁿ   Kavanah, Terry ^d   Triscott, Jean ^o   Dafoe, William ^p   McCartney, Neil ^q   Rodney, Paddy ^r   Howlett, Jonathan ^b   more..

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f Health Sciences Centre Calgary   (Canada)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

^h Queensway Carleton Hospital   (Canada)

ⁱ UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^j UNIVERSITY OF CALGARY   (Canada)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

^m Ottawa Cardiovascular Centre   (Canada)

ⁿ MCGILL UNIVERSITY   (Canada)

^o UNIVERSITY OF ALBERTA   (Canada)

^p UNIVERSITY OF OTTAWA   (Canada)

^q MCMASTER UNIVERSITY   (Canada)

^r UNIVERSITY OF VICTORIA   (Canada)

more..

Author keywords

Atrial fibrillation; Cardiovascular disease; Congestive heart failure; Elderly patient; Ischemic heart disease

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NEUROLEPTIC AGENT; NITRATE; RETEPLASE; SPIRONOLACTONE; TENECTEPLASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR DERIVATIVE; UNINDEXED DRUG; WARFARIN;

ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONSENSUS DEVELOPMENT; COUGHING; DEFIBRILLATION; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; ELDERLY CARE; EVIDENCE BASED MEDICINE; EXERCISE; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HEART SURGERY; HUMAN; MEDICAL ASSESSMENT; MEDICAL ETHICS; MEDICAL SOCIETY; ORTHOSTATIC HYPOTENSION; PATIENT CARE; QUALITY OF LIFE; SIDE EFFECT; SMOKING CESSATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; HUMANS;

EID: 3042514129     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)